Target intelligence / Profile preview

TP73 antisense RNA 2 (TP73-AS2)

Target
TP73-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA, Other
01

Overview

TP73 antisense RNA 2 (TP73-AS2) is a long non-coding RNA (lncRNA) gene transcribed from the antisense strand of the TP73 locus at chromosome 1p36.32 in humans[2]. TP73-AS2 belongs to a family of antisense lncRNAs that regulate the expression or activity of their sense gene partners, especially TP73, a member of the tumor suppressor p53 gene family. Although less characterized compared to the closely related TP73-AS1, TP73-AS2 is believed to exert regulatory effects on gene expression, possibly influencing cellular processes such as proliferation, apoptosis, and response to chemotherapy—mainly in the context of tumor biology[2]. Aberrant expression of antisense natures of the TP73 locus, including TP73-AS2, is increasingly recognized as a feature of diverse human cancers, suggesting potential utility as a biomarker or therapeutic target, but direct drug interventions have not yet been developed. *Note: The provided literature largely focuses on TP73-AS1, but the description and categorization for TP73-AS2 are inferred based on known antisense RNA functions at the TP73 locus and available database summaries. There is no evidence of misnaming or other correctness issues with TP73-AS2, though much less is known about it relative to TP73-AS1.*

Other names
RP5-1092A11.2TP73-AS2
02

Mechanism of action

Not applicable for drugs

03

Biological functions

Gene regulationPossible involvement in cell proliferationPossible involvement in apoptosisPossible involvement in migrationPossible involvement in invasionPossible involvement in chemoresistance
04

Disease associations

CancerOther
05

Safety considerations

Not established; general therapeutic challenges apply to lncRNA targeting (off-target effects, delivery, limited tissue specificity)
06

Biomarkers

Candidate prognostic or diagnostic biomarker for cancer

Beyond the preview

Go deeper on TP73 antisense RNA 2 (TP73-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TP73 antisense RNA 2 (TP73-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call